Mr. Market is currently offering MetLife, Inc. at $79.08.
The business passes 4 of 6 of Graham's defensive criteria — adequate but not exceptional.
At $79.08, the stock trades at a 14% premium to its Graham Number of $69.25. Graham would consider this price speculative.
There is no margin of safety at the current price. Graham would advise patience and waiting for a better entry point.
Conclusion: This stock is better suited for Graham's Enterprising investor — one willing to devote time and skill to security selection.
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it offers fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity and funded reinsurance solutions; credit insurance products; accident & health products covering hospitalization, cancer, critical illness, income protection, and scheduled medical reimbursement plans; and protection against long-term health care services. The company was incorporated in 1999 and is based in New York, New York.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Gross Profit % | N/A • | N/A | N/A | N/A | N/A |
| Operating Margin % | N/A • | N/A | N/A | N/A | N/A |
| Net Income % | 4.5% ▼ | 6.3% | 2.3% | 7.8% | N/A |
| Diluted EPS | 4.84 ▼ | 6.13 | 1.81 | 2.91 | N/A |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | $745.2B | $677.5B | $687.6B | $663.1B | N/A |
| Total Debt | $20.2B ↑ | $18.7B | $18.8B | $18.0B | N/A |
| Working Capital | N/A • | N/A | N/A | N/A | N/A |
| Years to Pay Debt | 5.97 | 4.23 | 11.93 | 3.40 | N/A |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | $17.1B ▲ | $14.6B | $13.7B | $13.0B | N/A |
| Owner Earnings | N/A | N/A | N/A | N/A | N/A |
| CapEx % of Net Income | N/A | N/A | N/A | N/A | N/A |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Capital Expenditure % of Net Income | N/A | N/A | N/A | N/A | N/A |
| Repurchase of Capital Stock | -$3.9B | -$3.2B | -$3.1B | -$3.3B | N/A |
| Free Cash Flow | $17.1B ▲ | $14.6B ▲ | $13.7B ▲ | $13.0B • | N/A • |
| Warren's Owner Earnings | N/A | N/A | N/A | N/A | N/A |
| Institution | % Owned | Shares |
|---|---|---|
| Vanguard Group Inc | 11.13% | 72,555,335 |
| Dodge & Cox Inc. | 8.01% | 52,252,050 |
| Blackrock Inc. | 7.67% | 50,034,179 |
| State Street Corporation | 3.90% | 25,442,132 |
| Price (T.Rowe) Associates Inc | 3.10% | 20,233,442 |
| Geode Capital Management, LLC | 1.98% | 12,890,555 |
| Pzena Investment Management LLC | 1.73% | 11,303,819 |
| Morgan Stanley | 1.68% | 10,938,865 |
MetLife, Inc. (MET) fundamental analysis — Overall grade D based on profitability, financial health, valuation and cash flow. Graham's Fair Value: $69.25. Margin of safety: 0%. Gross profit margin: N/A. Operating margin: N/A. Net margin: 4.5%. Market cap: $51.0B. Sector: Financial Services. Industry: Insurance - Life. Analysis powered by 360investing — free fundamental stock analysis based on Benjamin Graham and Warren Buffett principles.
Disclaimer: 360investing is provided for informational and educational purposes only and does not constitute financial, investment, legal, or tax advice. All data is sourced from public third-party providers and may be delayed, inaccurate, or incomplete. Past performance is not indicative of future results. Analysis, scores, and valuations are algorithmic and do not represent professional investment recommendations. Always conduct your own due diligence and consult a qualified financial adviser before making any investment decision. Use of this tool constitutes acceptance that 360investing and its operators bear no liability for decisions made based on information presented here.